334 filings
Page 14 of 17
8-K
09603
7 Aug 19
INmune Bio Reports Positive Preliminary Data from INB03 Phase I Clinical Trial in Cancer
4:30pm
8-K
u1iatu92k13gynv1wv
1 Aug 19
INmune Bio Co-Founder and CEO RJ Tesi Presents at Cambridge Healthcare Institute’s 7th Annual Immuno-Oncology Summit
4:30pm
8-K
615rjxz z9t0
30 Jul 19
INmune Bio Co-Founder and CEO Presents at 17th Annual Congress of
4:57pm
PRE 14A
a56 8gm8g5j2c
29 Jul 19
Preliminary proxy
4:05pm
EFFECT
h5rp6r
29 Jul 19
Notice of effectiveness
12:15am
424B3
sm8x3ds5
26 Jul 19
Prospectus supplement
4:40pm
UPLOAD
favkkj4awmn 60e
24 Jul 19
Letter from SEC
12:00am
CORRESP
3ed5exen35nf95x
24 Jul 19
Correspondence with SEC
12:00am
8-K
d94nahj
9 Jul 19
Other Events
4:05pm
8-K
uv9k3z l8av6e4
3 Jul 19
INmune Bio Co-Founder and CEO Presents at Maxim Group’s Conference on Alzheimer’s Disease
5:00pm
424B3
x2zxshkeb3wytu 45bf
3 Jul 19
Prospectus supplement
1:03pm
EFFECT
nc3iu7e0n8r3k 6e03
3 Jul 19
Notice of effectiveness
12:15am
8-K
1cyzan63zyccg8s wnf
28 Jun 19
INmune Bio Announces Publication of Data on INKmune Primed NK cells in Peer-Reviewed Journal PLOS ONE
4:05pm
CORRESP
2idy fsdk
27 Jun 19
Correspondence with SEC
12:00am
UPLOAD
oo9urvrh 2evmap
27 Jun 19
Letter from SEC
12:00am
8-K
w4zvsjj
26 Jun 19
Regulation FD Disclosure
1:55pm
8-K
adt1yqsdg
24 Jun 19
Regulation FD Disclosure
6:02am
8-K
pufqvm
20 Jun 19
Regulation FD Disclosure
12:00am